 |
 |
 |
|
In Vitro Assessment of Potential Drug-Drug Interactions Between Telaprevir and Cyclophilin Inhibitors in the Treatment of Chronic Hepatitis C
|
|
|
Reported by Jules Levin AASLD Nov 5-8 2011
SeongHee Park, Weslyn Ward, Beth Beaudet, Sara Schock, Ryan Randolph, Eric Gaukel, and Stephen Wring,
SCYNEXIS Inc., Research Triangle Park, NC, United States








|
|
|
 |
 |
|
|